Patents by Inventor David W. Dodick

David W. Dodick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injection paradigm for administration of botulinum toxins
    Patent number: 11819541
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: November 21, 2023
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin, David W. Dodick
  • NUTRITIONAL HEALTH SUPPLEMENTS
    Publication number: 20230147612
    Abstract: A nutritional health supplement is provided for the brain.
    Type: Application
    Filed: November 23, 2020
    Publication date: May 11, 2023
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventor: DAVID W DODICK
  • NUTRITIONAL HEALTH SUPPLEMENTS
    Publication number: 20220248734
    Abstract: A nutritional health supplement is provided for the brain. In one exemplary embodiment, a nutritional health supplement comprises an antioxidant that delays neuronal death under excitotoxic conditions, a neuroprotective agent having antioxidant, anti-inflammatory, and anti-apoptic properties, and a neuroprotective agent that is a precursor for glutathione synthesis. In another exemplary embodiment, a nutritional health supplement comprises an antioxidant that delays neuronal death under excitotoxic conditions, a neuroprotective agent that is a precursor for glutathione synthesis, a NAD+ precursor, a ketone body or ketone precursor, and an antioxidant with free-radical species-deactivating properties.
    Type: Application
    Filed: March 19, 2020
    Publication date: August 11, 2022
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventor: David W. DODICK
  • Injection paradigm for administration of botulinum toxins
    Patent number: 8501195
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: August 6, 2013
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Mitchell F. Brin, Sheena K. Aurora, David W. Dodick
  • Injection Paradigm for Administration of Botulinum Toxins
    Publication number: 20120053126
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: March 30, 2011
    Publication date: March 1, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Catherine C. TURKEL, Mitchell F. Brin, Sheena K. Aurora, David W. Dodick